Ticker: HALO

Company: HALOZYME THERAPEUTICS INC

Person: Helen Torley, director, officer

Transaction date: Feb. 20, 2026

Reporting date: Feb. 24, 2026

Average share price: -82.92347276857446

Sold 18049.0 shares for 1496685.76